Cite Filings / IMDX / 0001493152-24-052337

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Insight Molecular Diagnostics Inc. Filed 2024-12-27 Acc 0001493152-24-052337

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2024-12-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2024-12-27 4 10% owner bought 90,219 shares at $2.13 ($192,166)
2024-12-27 3 Initial Statement of Ownership
2024-12-26 4 Director bought 12,500 shares at $2.11 ($26,350)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…